AACR logo

More articles from Structural Biology

RTKs Can Form Membraneless Granules to Drive Cytoplasmic RAS Signaling
Cancer Discovery Jun 2021, 11 (6) 1316; DOI: 10.1158/2159-8290.CD-RW2021-059
Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
Cancer Discovery Mar 2021, 11 (3) OF8; DOI: 10.1158/2159-8290.CD-RW2021-009
Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
Cancer Discovery Mar 2021, 11 (3) 529; DOI: 10.1158/2159-8290.CD-RW2021-004
BI-3802 Promotes Polymerization and Degradation of Oncogenic BCL6
Cancer Discovery Feb 2021, 11 (2) 220; DOI: 10.1158/2159-8290.CD-RW2020-173
Checkpoint Kinase MEC1 (ATR) Structure Reveals Activation Mechanism
Cancer Discovery Jan 2021, 11 (1) 10; DOI: 10.1158/2159-8290.CD-RW2020-170
Trametinib Promotes MEK Binding to the RAF-Family Pseudokinase KSR
Cancer Discovery Nov 2020, 10 (11) 1624; DOI: 10.1158/2159-8290.CD-RW2020-138
Therapeutic CD20-Targeting Antibodies Differ in Their Binding Modes
Cancer Discovery Oct 2020, 10 (10) OF6; DOI: 10.1158/2159-8290.CD-RW2020-122
Ubiquitination Causes Fanconi Anemia–Linked ID Complex Ring Formation
Cancer Discovery May 2020, 10 (5) OF12; DOI: 10.1158/2159-8290.CD-RW2020-043
PARP1/2 and Accessory Factor HPF1 Interlock to Form a Joint Active Site
Cancer Discovery Apr 2020, 10 (4) 486; DOI: 10.1158/2159-8290.CD-RW2020-024
Structure of CD20 Bound to Rituximab Reveals Mechanistic Information
Cancer Discovery Apr 2020, 10 (4) 488; DOI: 10.1158/2159-8290.CD-RW2020-031

Main menu